Recent Updates
Recently added Catalysts
PEN

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for February 26, 2019 Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2018 ...

Key Takeaway: ALAMEDA, Calif. , Jan. 30, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2018 after market close on Tuesday, February 26, 2019 at 4:30 PM Eastern Time. A press

Full Press Release Details

ALAMEDA, Calif. , Jan. 30, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2018 after market close on Tuesday, February 26, 2019 at 4:30 PM Eastern Time. A press release with fourth quarter and full year 2018 financial results will be issued after market close that day.
Webcast & Conference Call Information The conference call can be accessed live over the phone by dialing (866) 393-4306 for domestic callers or (734) 385-2616 for international callers (conference id: 6696873), or the webcast can be accessed on the "Events" section under the "Investors" tab of the Company's website at: www.penumbrainc.com . The webcast will be available on the Company's website for at least two weeks following the completion of the call.
About Penumbra Penumbra, Inc., headquartered in Alameda, California , is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States , most of Europe , Canada and Australia , and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com .
Investor Relations Penumbra, Inc. 510-995-2461 [email protected]
SOURCE Penumbra, Inc.

Related Links

21 %

Last updated: Jan 30, 2019